Literature DB >> 7692407

North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG defibrillator code.

A D Bernstein1, A J Camm, J D Fisher, R D Fletcher, R H Mead, A W Nathan, V Parsonnet, A F Rickards, N P Smyth, R Sutton.   

Abstract

A new generic code, patterned after and compatible with the NASPE/BPEG Generic Pacemaker Code (NBG Code) was adopted by the NASPE Board of Trustees on January 23, 1993. It was developed by the NASPE Mode Code Committee, including members of the North American Society of Pacing and Electrophysiology (NASPE) and the British Pacing and Electrophysiology Group (BPEG). It is abbreviated as the NBD (for NASPE/BPEG Defibrillator) Code. It is intended for describing the capabilities and operation of implanted cardioverter defibrillators (ICDs) in conversation, record keeping, and device labeling, and incorporates four positions designating: (1) shock location; (2) antitachycardia pacing location; (3) means of tachycardia detection; and (4) antibradycardia pacing location. An additional Short Form, intended only for use in conversation, was defined as a concise means of distinguishing devices capable of shock alone, shock plus antibradycardia pacing, and shock plus antitachycardia and antibradycardia pacing.

Entities:  

Mesh:

Year:  1993        PMID: 7692407     DOI: 10.1111/j.1540-8159.1993.tb01809.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator.

Authors:  Pierpaolo Lupo; Riccardo Cappato; Giovanni Di Leo; Francesco Secchi; Giacomo D E Papini; Sara Foresti; Hussam Ali; Guido M G De Ambroggi; Antonio Sorgente; Gianluca Epicoco; Paola M Cannaò; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

2.  Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference.

Authors:  J D Madigan; A F Choudhri; J Chen; H M Spotnitz; M C Oz; N Edwards
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

Review 3.  The patient with a pacemaker or related device.

Authors:  M E Bourke
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

4.  [Pacemaker, defibrillator and co : Perioperative handling of cardiac implantable electronic devices].

Authors:  K Ott; H Pressl; M Schramm; A Wutzl
Journal:  Anaesthesist       Date:  2017-10       Impact factor: 1.041

Review 5.  Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials-Precise patient selection and measurable benefit.

Authors:  Richard Sutton; Jelle S Y de Jong; Julian M Stewart; Artur Fedorowski; Frederik J de Lange
Journal:  Heart Rhythm       Date:  2020-02-06       Impact factor: 6.343

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.